The effects of chronic ethanol administration on the acute hemodynamic effects of clonidine were investigated in conscious radiotelemetered spontaneously hypertensive rats (SHRs). Changes evoked by clonidine (30 g/kg i.p.) in blood pressure, heart rate, and their variability were evaluated in ethanol [2.5 or 5% (w/v), 12 weeks] and pair-fed control rats. The blood pressure variability was determined as the standard deviation of the mean arterial pressure (SDMAP). Two heart rate variability indices were used, the standard deviation of beat-tobeat intervals (SDRR) and the root mean square of successive beat-to-beat differences in R-R interval durations (rMSSD). Compared with control rats, ethanol (2.5 and 5%)-fed rats exhibited concentration-related reductions in mean arterial pressure (MAP) and SDMAP versus no change in heart rate variability. In control rats, clonidine caused a significant reduction in MAP that continued for at least 5 h and was associated with significant reductions in SDMAP, SDRR, and rMSSD, responses that are consistent with the inhibition of central sympathetic tone. The hypotensive effect of clonidine was attenuated by ethanol in a concentration-related manner. The maximum reductions in MAP elicited by clonidine in ethanol (2.5 and 5%)-fed rats amounted to Ϫ23.4 Ϯ 2.8 and Ϫ15.1 Ϯ 1.5 mm Hg, respectively, compared with Ϫ35.4 Ϯ 1.2 mm Hg in control rats. The clonidine-induced reductions in SDMAP, SDRR, and rMSSD were also significantly attenuated by ethanol. These findings suggest that the attenuation of MAP and heart rate variability responses elicited by clonidine in ethanolfed SHRs reflects alterations in the sympathovagal balance, which may be implicated in the antagonistic hemodynamic interaction between the two drugs.
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Clonidine is a centrally acting antihypertensive drug that decreases blood pressure predominantly via stimulation of ␣ 2 -adrenergic (Timmermans and van Zwieten, 1982) and imidazoline (Tibirica et al., 1991) receptors in the brainstem, resulting in suppression of central sympathetic outflow. Sympathoinhibition has also been implicated in the clonidine-induced reductions in blood pressure and heart rate variability as determined by frequency-and time-domain analyses (Grichois et al., 1990; Elghozi et al., 1991; Janssen et al., 1991; Tulen et al., 1993) . The reduction in hemodynamic variability by clonidine is important at least in two clinical settings. First, the long-term reduction in blood pressure variability by clonidine may contribute to the regression of ventricular and vascular hypertrophy in hypertensive patients (Timio et al., 1987; Strauer, 1988) . Second, by reducing blood pressure and heart rate variability, clonidine promotes hemodynamic stability in patients undergoing surgery and reduces anesthetic requirements (Nishikawa et al., 1991) . It is noteworthy that 1) blood pressure and heart rate variability is an indirect measure of cardiovascular autonomic balance and 2) oscillation abnormalities in these hemodynamic variables are associated with life-threatening cardiovascular events such as sudden stroke, ventricular arrhythmias and myocardial infarction (Stein et al., 1994) .
Regular use of ethanol is associated with inadequate control of blood pressure in treated hypertensive patients (Volicer et al., 1978; Puddey et al., 1987) . This clinically important phenomenon has been demonstrated in experimental animals in our previous reports, which showed that ethanol, administered acutely or chronically, counteracts the hypotensive effect of clonidine and related antihypertensive agents (Abdel-Rahman et al., 1992; Abdel-Rahman, 1994; El-Mas et al., 1994b) . In contrast, peripherally mediated hypotensive responses elicited by hydralazine, nitroprusside, or hexamethonium are not influenced by ethanol (AbdelRahman et al., 1992; El-Mas and Abdel-Rahman, 1999) . Cen-tral sympathetic tone seems to play a critical role in the ethanol-clonidine hemodynamic interaction because the counteraction of clonidine hypotension by ethanol is associated with remarkable increases in plasma norepinephrine levels (El-Mas et al., 1994b; El-Mas and Abdel-Rahman, 1999) and in norepinephrine electrochemical signal in the rostral ventrolateral medulla (Mao and Abdel-Rahman, 1998) . It is noteworthy, however, that peripheral hemodynamic effects of ethanol may influence its interaction with antihypertensive drugs. Moderate doses of ethanol dilate cutaneous blood vessels partly through a direct action on these vessels (Turlapaty et al., 1979) .
Although ethanol counteraction of clonidine-evoked hypotension has been documented (Abdel-Rahman, 1994; El-Mas et al., 1994b) , whether ethanol adversely affects the beneficial actions of clonidine on blood pressure and heart rate oscillations has not been investigated. This possibility was investigated in the present study by evaluating the effect of chronic ethanol feeding on clonidine-evoked acute changes in blood pressure, heart rate, and their variability in radiotelemetered SHRs. The unique aspects of the current study are as follows: 1) using radiotelemetry for hemodynamic measurement, which permits continuous and simultaneous measurements of blood pressure and heart rate under minimal stressful conditions (El-Mas and Abdel-Rahman, 2000; Rekik et al., 2002) ; 2) studying the effect of two different concentrations of ethanol [2.5 or 5% (w/v)] on the hemodynamic actions of clonidine to establish a concentration-effect relationship; and 3) ethanol was given in liquid diet and the rats (ethanol or control) were pair fed to ensure similar fluid and nutrient intakes as in our previous studies (El-Mas and Abdel-Rahman, 2000; Rekik et al., 2002) . The achievement of a similar fluid intake was important because of its impact on hemodynamics (Bouby et al., 1990) . It is worth mentioning that the doses of ethanol used in the present study have been shown in our previous studies (Rekik et al., 2002) to produce blood ethanol concentrations comparable with those attained in humans after consumption of moderate to intoxicating amounts of ethanol (Potter and Beevers, 1984; Abdel-Rahman et al., 1987) .
Materials and Methods
Male spontaneously hypertensive rats (10 -11 weeks, 250 -300 g; Taconic Farms, Germantown, NY) were used in the present study. Upon arrival, the rats were housed individually in standard plastic cages and allowed free access to water and Purina chow and were maintained on a 12-h light/dark cycle with light off at 7:00 PM. The room temperature was maintained at 22 Ϯ 1°C. After 1-week acclimatization, rats were fed a regular Lieber-DiCarli liquid diet (Dyets Inc., Bethlehem, PA) for another week before ethanol feeding. Rats received the diet daily at 8:30 AM. Experiments were carried out in accordance with the Declaration of Helsinki and with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the U.S. National Institutes of Health.
Ethanol Feeding. Three groups of SHRs matched for body weight were used in the present study. Two groups were provided a regular Lieber-DeCarli liquid diet (Lieber and DeCarli, 1982) containing 2.5 or 5% (w/v) ethanol (18 and 36% of total caloric intake, respectively; n ϭ 5 each) as described in our previous studies (El-Mas and Abdel-Rahman, 2000; Rekik et al., 2002) . The third group of rats (controls; n ϭ 4) was pair fed and received isocaloric amount of dextrin/maltose (89.6 g/l) in place of ethanol, which allowed similar nutrient intake and fluid consumption to that of ethanol-fed rats.
Fresh diets were prepared every other day and stored in the refrigerator until dispensed. Rats were maintained on the ethanol or control diet for 12 weeks.
Telemetry System. The telemetry system (Data Sciences International, St. Paul, MN) used in this study has been described in our previous studies (El-Mas and Abdel-Rahman, 2000; Rekik et al., 2002) . The system consists of five major components: 1) implantable transmitter unit for measurement of blood pressure, 2) radio receiver to receive telemetered signals, 3) ambient pressure monitor to measure absolute atmospheric pressure, 4) a consolidation matrix to multiplex multiple cage signals to the computer, and 5) a PC-based data acquisition system to process signals. The implanted sensor consisted of a fluid-filled catheter (0.7 mm in diameter and 15 cm in length; model TA11PA-C40) connected to a highly stable low-conductance strain-gauge pressure transducer, which measured the absolute arterial pressure relative to a vacuum, and a radio frequency transmitter. The tip of the catheter was filled with a viscous gel that prevented blood reflux and was coated with an antithrombogenic film to inhibit thrombus formation and maintain patency. The distal 1 cm of the catheter consisted of a thin-walled thermoplastic membrane, whereas the remainder of the catheter was composed of a thick-walled low-compliance urethane. The implants (2.5 cm in length and 1.2 cm in diameter) weighed 9 g and had a typical battery life of 6 months. Implants were gas sterilized and provided precalibrated (relative to vacuum) by the manufacturer, and calibrations were verified to be accurate within 3 mm Hg (Brockway et al., 1991) . A radio receiver platform (RLA1010; Data Sciences International) connected the radio signal to digitized input that was sent to a dedicated personal computer (Compaq Pressario 9548). Arterial pressures were calibrated by using an input from an ambient-pressure monitor (C11PR; Data Sciences Int.).
Transmitter Implantation. The method described in our previous studies (El-Mas and Abdel-Rahman, 2000; Rekik et al., 2002) was adopted. The rats were anesthetized with i.p. injection of a mixture of ketamine (90 mg/ml; Ketaject) and xylazine (10 mg/ml; Xyla-ject). The abdomen was opened with a midline incision (4 cm). Another incision (1.5 cm) was made along the inner thigh to expose the femoral artery. The abdominal wall was pierced with a large-bore syringe needle (15 gauge) from the femoral side into the peritoneal cavity. The implant body was placed in the peritoneal cavity and the catheter (15 cm) was passed caudally through the syringe needle into the thigh area. A 5-cm portion of the catheter was inserted into the femoral artery and secured in place with sutures. The abdominal muscle was closed with nonabsorbable suture incorporating the implant suture rib with alternating stitches. The skin (abdomen and thigh) was closed with surgical clips. Each rat received a subcutaneous injection of the analgesic ketorolac tromethamine (2 mg/kg; Toradol) and an intramuscular injection of 60,000 U of penicillin G benzathine and penicillin G procaine in an aqueous suspension (Durapen). Individual rat cages were placed on the top of the radio receivers, and all data were collected using a computerized data acquisition system (Dataquest ART; Data Sciences International). The system is designed to cycle from animal to animal. Transmitter implantation was performed 9 weeks after ethanol or control diet feeding. Rats were left for three additional weeks before starting the experiment (i.e., clonidine or saline administration).
Hemodynamic Effects of Clonidine. This experiment investigated the influence of chronic ethanol feeding on the acute hemodynamic effects of clonidine on blood pressure, heart rate, and their variability in conscious telemetered SHRs. After 12 weeks of ethanol feeding, SHRs received a single i.p. injection of saline (1 ml/kg) and 3 days later, clonidine (30 g/kg). Blood pressure and heart rate were followed for 7 h after clonidine or saline administration. Waveforms of blood pressure for each rat was sampled at a rate of 500 Hz for 10 s every 10 min. Changes in MAP and heart rate evoked by clonidine from baseline values in pair-fed rats receiving liquid diet with or without ethanol [2.5 or 5% (w/v)] were averaged in 20-min blocks for analysis. 
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Time-Domain Analyses. Three time-domain parameters were used to measure hemodynamic variability. The standard deviation of the mean arterial pressure (SDMAP) was taken as a measure of blood pressure variability. Heart rate variability was determined by computing the standard deviation of beat-to-beat intervals (SDRR) and the root mean square of successive beat-to-beat differences in R-R interval durations (rMSSD) (Stein et al., 1994; Sgoifo et al., 1997; Visser et al., 2002) . The RR intervals were computed from the heart rate values (i.e., the reciprocal of heart rate in milliseconds) as in our previous study (Abdel-Rahman et al., 1987) . Our previous studies and others have shown that the time-domain indices of blood pressure and heart rate variability correlate well with the frequencydomain measurements (Stein et al., 1994; Sgoifo et al., 1997; El-Mas and Abdel-Rahman, 2000) . The SDRR is comparable with the total power of the spectrum of RR variability, which measures the overall autonomic balance of the heart. The rMSSD is largely validated as a measure of the parasympathetic input to the heart and, therefore, correlates with the high-frequency power of the spectrum (Stein et al., 1994; Sgoifo et al., 1997) . Changes in the short-term variability of MAP and heart rate were calculated by averaging each 1-h values (i.e., six successive values measured at 10-min intervals) of SDMAP, SDRR, and rMSSD for a total of 7 h. Baseline values of different hemodynamic variables were taken as the average of the 3-h period that preceded clonidine or saline administration.
Measurement of Plasma Ethanol Concentration. A blood sample was taken from each rat at the end of the study and its ethanol content was determined by the enzymatic method as in our previous studies Abdel-Rahman, 1999, 2000) .
Drugs. Clonidine hydrochloride (Sigma-Aldrich, St. Louis, MO), Ketaject (ketamine), Xyla-ject (xylazine) (Phoenix Pharmaceuticals Inc., St Joseph, MI), Toradol (ketorolac tromethamine; Abbott Laboratories, Chicago, IL), Durapen (penicillin G benzathine and penicillin G procaine; Vedco Inc., Overland Park, KS), and ethanol (Midwest Grain Products Co., Weston, MO) were purchased from commercial vendors.
Statistical Analysis. All values are expressed as means Ϯ S.E.M. Comparisons of the hemodynamic effects of clonidine with the corresponding baseline or time-course postsaline responses in control and ethanol-fed SHRs were performed with the repeated measures two-way analysis of variance followed by a Newman-Keuls post hoc test. This test distinguishes the within-group responses from the between-group responses. These analyses were performed by SAS software release 6.04 (SAS Institute Inc., Cary, NC) as in our previous study (El-Mas and Abdel-Rahman, 1997) . Probability levels less than 0.05 were considered significant.
Results
Effect of Ethanol on Blood Pressure, Heart Rate, and Their Variability. The body weight of pair-fed control and ethanol-fed (2.5 and 5%) SHRs measured at the end of the study were 405 Ϯ 5, 395 Ϯ 6, and 361 Ϯ 11 g, respectively. Blood ethanol concentrations measured 12 weeks after ethanol feeding (2.5 and 5%) amounted to 69 Ϯ 12 and 186 Ϯ 29 mg/dl, respectively. The effect of ethanol on blood pressure, heart rate, and their variability compared with control liquid diet are shown in Table 1 . Ethanol feeding produced significant (P Ͻ 0.05) and concentration-dependent decreases in MAP compared with control values (Table 1) . Ethanol also reduced MAP variability (SDMAP); the reduction was statistically significant, compared with control values, only with the higher concentration of ethanol. The heart rate and the time-domain indices of heart rate variability (SDRR and rMSSD) showed slight and insignificant reductions by ethanol (Table 1) .
Effect of Clonidine on Blood Pressure, Heart Rate, and Their Variability. Baseline hemodynamic values in ethanol and control groups before saline administration were similar to the preclonidine values (data not shown). The time-course effects of a single dose of clonidine (30 g/kg i.p.) or equal volume of saline on blood pressure, heart rate, and their variability in control SHRs are depicted in Tables 2 and  3 . Compared with the corresponding baseline value, saline administration had no effect on MAP except for a significant increase observed at 20 min ( Table 2 ). The heart rate was significantly increased in saline-treated rats during the last 3 h of the study (Table 2) . Hemodynamic variability (SDMAP, SDRR, and rMSSD) was not affected by saline administration except for a significant increase in SDMAP at 1 h and rMSSD at 6 h (Table 3) . Clonidine significantly increased MAP at 20 min that was followed by significant (P Ͻ 0.05) reductions in MAP, compared with the corresponding baseline and postsaline values ( Table 2 ). The hypotensive effect of clonidine was observed 40 min after its administration and continued for at least 5 h (Table 2) . Compared with the corresponding baseline value, a maximum hypotensive response to clonidine of Ϫ35.5 Ϯ 1.2 mm Hg was obtained at 60 min (Table 2 ). The heart rate was significantly reduced by clonidine during the first 40 min compared with corresponding postsaline values and, like the saline effect, showed significant increases by the end of the study (Table 2) . Clonidine elicited significant (P Ͻ 0.05) reductions in the MAP variability (SDMAP) that started at 2 h and continued for the following 3 h (Table 3 ). The time-domain indices of heart rate variability, SDRR and rMSSD, were also reduced by clonidine. These reductions were statistically significant, compared with corresponding baseline and postsaline values, at 1, 2, and 3 h for SDRR and during the first 2 h for rMSSD (Table 3) .
Ethanol-Clonidine Hemodynamic Interaction. Changes evoked by chronic ethanol feeding [2.5 or 5% (w/v), 12 weeks] in the responses of MAP, heart rate, and their variability to clonidine are illustrated in Figs. 1 and 2 . Compared with its 
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at ASPET Journals on August 30, 2017 jpet.aspetjournals.org effect in control rats, the hypotensive effect of clonidine was significantly (P Ͻ 0.05) attenuated in ethanol-fed rats in a concentration-related manner (Fig. 1A) . The hypotensive action of clonidine in SHRs receiving the lower concentration of ethanol (2.5%) was significantly smaller than corresponding control values during the first 1 h of clonidine administration (Fig. 1A) . On the other hand, the attenuation of clonidine hypotension by the higher concentration of ethanol (5%) was evident for approximately 5 h (Fig. 1A) . Similarly, ethanol elicited concentration-dependent attenuation of clonidine-evoked reductions in MAP and heart rate variability indices (SDMAP, SDRR, and rMSSD) (Fig. 2) . These effects of ethanol were statistically significant, compared with control values, at 3 and 4 h for SDMAP ( Fig. 2A) and at 1 h for SDRR (Fig. 2B ) and rMSSD (Fig. 2C) . Ethanol feeding (5%) caused significant increases in heart rate only during the first 60-min period of the study (Fig. 1B) . To eliminate a possible role for the differences in baseline hemodynamic values of control and ethanol-fed rats (Table 1) in the antagonistic ethanol-clonidine interaction, responses to clonidine were expressed as a percentage of baseline (i.e., preclonidine) values and compared in the three groups of rats. The percentage reductions in MAP (Fig. 3A) and its variability index (SDMAP; Fig. 3B ) elicited by clonidine were attenuated in ethanol-fed rats in a concentration-dependent manner; the effect of the higher concentration of ethanol (5%) was statistically significant (P Ͻ 0.05) compared with control values. Also, the percentage reductions in SDRR and rMSSD evoked by clonidine were virtually abolished by 2.5% ethanol (Fig. 3, C and D) and transformed into significant increases by 5% ethanol (Fig. 3, C and D) .
Discussion
Our previous studies have shown that ethanol compromises the blood pressure lowering effect of centrally acting antihypertensive agents (Abdel-Rahman et al., 1992; AbdelRahman, 1994) . In the present study, we tested the hypothesis that alteration of autonomic (sympathovagal) balance contributes to the attenuation of clonidine hypotension in ethanol-fed rats. This objective was accomplished by investigating the influence of ethanol feeding on clonidine-evoked changes in blood pressure, heart rate, and their variability in telemetered SHRs. The time-domain measurement of blood pressure and heart rate variability was used in the present study to determine changes in the cardiovascular autonomic balance. Time-domain indices correlate with frequency-domain measurements and, therefore, provide a reliable evaluation of cardiovascular autonomic balance (Stein et al., 1994; Sgoifo et al., 1997) . The results showed that clonidine produced hypotension that was associated with significant reductions in the time-domain indices of MAP (SDMAP) and heart rate (SDRR and rMSSD) variability, which may reflect the clonidine-evoked inhibition of central sympathetic activity (Grichois et al., 1990; Elghozi et al., 1991; Janssen et al., 1991; Tulen et al., 1993) . Ethanol feeding, concentration dependently, attenuated the hypotensive effect of clonidine and the associated reductions in MAP and heart rate variability. These findings provide evidence that implicates alterations in sympathovagal balance of the cardiovascular system in the antagonistic ethanol-clonidine hemodynamic interaction. The present study showed that clonidine elicited hypotension in control SHRs and significantly reduced time-domain indices of blood pressure and heart rate variability (SDMAP, SDRR, and rMSSD). These findings are in agreement with previous reports that used time-or frequency-domain measurements and highlight a role for the concomitant reduction in central sympathetic outflow in mediating clonidine effects (Grichois et al., 1990; Elghozi et al., 1991; Janssen et al., 1991; Tulen et al., 1993) . The brief pressor effect that preceded clonidine hypotension might be related to the stress associated with the intraperitoneal injection of the drug because a similar response followed saline administration. It is generally accepted that the reduction in peripheral vascular resistance subsequent to sympathoinhibition is the principal mechanism underlying the hypotensive effect of clonidine (Mao and Abdel-Rahman, 1998; El-Mas and Abdel-Rahman, 1999) . The reduction caused by clonidine in the variability of adjacent interbeat intervals (rMSSD), which largely reflects cardiac vagal activity (Stein et al., 1994; Sgoifo et al., 1997) , may be secondary to the reduction in sympathetic outflow to maintain the sympathovagal balance. Similar inhibitory ef- jpet.aspetjournals.org fects of clonidine on the frequency-domain indices of sympathetic and parasympathetic outflows have been demonstrated in humans (Tulen et al., 1993) . Several studies have pointed out that heart rate and blood pressure variabilities are correlated and exhibit feedback and feed-forward interactions (Di Rienzo et al., 1991; Saul et al., 1991; Cerutti et al., 1994) . In addition to sympathoinhibition, two others factors have been proposed to contribute to the hemodynamic stability produced by clonidine. First, Grichois et al. (1990) and Elghozi et al. (1991) suggested that the increased arterial baroreflex responsiveness by clonidine might contribute to the better control of blood pressure and heart rate oscillations. Notably, baroreflex activity is inversely related to blood pressure variability (Su et al., 1986) . Our own findings and those of others have shown that partial or complete arterial baroreceptor denervation results in greater fluctuations in blood pressure (Krieger, 1964; El-Mas et al., 1994a) . Second, the sedative effect of clonidine may favor hemodynamic stability. This view gains support from the observation that clonidine significantly reduces blood pressure variability only during the dark period when the rats are active (Janssen et al., 1991) .
The primary goal of the present study was to study the influence of chronic ethanol feeding on clonidine-evoked changes in hemodynamic variability and its possible involvement in the antagonistic effects of the two drugs on blood pressure. The time-domain measurement of hemodynamic variability was used, for the first time, to evaluate the role of the sympathetic activity in the antagonistic hemodynamic interaction between ethanol and centrally acting antihypertensive agents. Our previous studies measured norepinephrine levels in plasma and brainstem to implicate central sympathetic tone in ethanol-clonidine hemodynamic interaction (El-Mas et al., 1994b; Mao and Abdel-Rahman, 1998; El-Mas and Abdel-Rahman, 1999 ). The present results showed that the hypotensive effect of clonidine was significantly attenuated by ethanol in a concentration-dependent manner. The maximum decrease in blood pressure produced by clonidine in SHRs receiving 2.5 and 5% ethanol amounted to Ϫ23.4 Ϯ 2.8 and Ϫ15.7 Ϯ 1.2 mm Hg, respectively, compared with Ϫ35.4 Ϯ 1.2 in pair-fed controls. Ethanol also attenuated the parallel reductions in blood pressure and heart rate variability elicited by clonidine. Given the positive correlation between clonidine-evoked reduction in hemodynamic variability and sympathoinhibition (Grichois et al., 1990; Elghozi et al., 1991; Janssen et al., 1991; Tulen et al., 1993) and the importance of sympathoexcitation in the ethanol counteraction of centrally evoked hypotension (El-Mas et al., 1994b; Mao and Abdel-Rahman, 1998) , the attenuation by ethanol of clonidine effects on blood pressure and heart rate variability supports the involvement of the sympathetic component in the interaction. Together, these findings demonstrate that chronic ethanol administration compromises clonidine-induced hemodynamic stability and sympathoinhibition, which may contribute to the antagonistic effect of the two drugs on blood pressure.
It may be argued that the reduced effectiveness of clonidine on blood pressure and hemodynamic variability in ethanol-fed rats might be related to differences in the baseline values of these parameters in ethanol-fed and control rats. As shown in Table 1 , the baseline blood pressure and its time-domain variability index (SDMAP) were significantly and concentration dependently reduced by ethanol. The baseline indices of heart rate variability also exhibited slight reductions in ethanol-fed rats. The notion that long-term ethanol administration lowers blood pressure agrees with jpet.aspetjournals.org earlier reports, including ours (Beilin et al., 1992; El-Mas and Abdel-Rahman, 2000; Rekik et al., 2002) , and may be attributed to ethanol-induced myocardial depression (Kelback et al., 1985) , vasodilation (Turlapaty et al., 1979) , or ␣-adrenergic blockade (Abdel-Rahman et al., 1985) . Nonetheless, the possibility that the reduced responsiveness to clonidine in ethanol-fed rats relates to differences in baseline values seems unlikely because of the following three observations. First, the attenuated hemodynamic effects of clonidine in ethanol-fed rats were still evident when the responses were expressed as percentages of baseline values (Fig. 3) . The percentage of reductions in all measured variables was significantly attenuated in ethanol-fed rats compared with their control counterparts. In effect, clonidine increased heart rate variability indices (SDRR and rMSSD) in rats receiving the higher concentration of ethanol. Second, the hypotensive response to intracisternally administered clonidine was attenuated in ethanol chronically fed SHRs whose baseline blood pressure was similar to that of control SHRs (Abdel-Rahman, 1994) , suggesting that differences in baseline blood pressure in the present study may not account for the attenuated clonidine hypotension in ethanol-fed rats. Third, the antagonistic ethanol-clonidine hemodynamic interaction has been demonstrated in arterial barodenervated rats (El-Mas et al., 1994b ; El-Mas and Abdel-Rahman, 1997) whose baseline blood pressure was less than that seen in ethanol-fed rats in the present study. These findings indicate that the ethanolclonidine interaction may not be related to baseline hemodynamic differences but rather to their antagonistic effects on circulatory controlling mechanisms.
Findings of acute studies from our laboratory have shown that the counteraction by ethanol of the hypotensive and sympathoinhibitory effects of clonidine is demonstrated only when ethanol is administered during the hypotensive response, i.e., subsequent to clonidine (Mao and Abdel-Rahman, 1998; El-Mas and Abdel-Rahman, 1999), but not when given before clonidine (El-Mas and Abdel-Rahman, 1997; Mao and Abdel-Rahman, 1998) . This led to the suggestion that the preexisting sympathoinhibitory effect of clonidine acts to unmask the sympathoexcitatory and hence the pressor effect of ethanol (El-Mas et al., 1994b, El-Mas and AbdelRahman, 1997; Mao and Abdel-Rahman, 1998) . These findings may be in contrast with the present observation that long-term ethanol pretreatment attenuated clonidine hypotension. The reason for the discrepancies in the effect of acute (no change) and chronic (attenuation) ethanol pretreatment on the hypotensive effect of clonidine is not clear. Interestingly, chronic feeding of ethanol in SHRs has been shown to reduce the density of ␣ 2 -adrenergic receptors in the nucleus tractus solitarius (El-Mas and Abdel-Rahman 2001), a possible brainstem target for clonidine hypotension (Kubo and Misu, 1981) . Biochemical evidence is also available that chronic ethanol reduces ␣ 2 -receptor sensitivity in the SHR brain (Szmigielski et al., 1989) . Together, these findings may implicate the reduced binding and functional activity of central ␣ 2 -receptors in the attenuated hypotensive action of clonidine in ethanol-fed rats.
In conclusion, time-domain measurements of hemodynamic variability provide evidence that implicates the cardiovascular autonomic balance in the antagonistic ethanolclonidine hemodynamic interaction. Clonidine reduced blood pressure as well as blood pressure and heart rate variability in SHRs, and these effects were attenuated by ethanol in a concentration-dependent manner. These findings add new insight into the understanding of mechanism involved in the reduced therapeutic effectiveness of some antihypertensive medications in regular alcohol users (Volicer et al., 1978; Puddey et al., 1987) and highlight a possible adverse effect for ethanol on clonidine-induced hemodynamic stability during surgical procedures (Nishikawa et al., 1991) and in cardiac and vascular hypertrophy (Timio et al., 1987; Strauer, 1988) .
